At BioCanRx, we work to advance cancer immunotherapies through the complex pathway from bench to bedside. Here, Dr. Erin Bassett, our Director of Regulatory Affairs and Policy, explains how immunotherapies are regulated in Canada, why these biologic treatments pose unique manufacturing and regulatory challenges, and how clinical trials play a critical role in evaluating safety and efficacy. Take a few minutes to understand the complex landscape facing immunotherapies in Canada––and the exciting opportunities that lie ahead.